Feb 23, 2018 - Orbimed Advisors Llc Buys Regeneron Pharmaceuticals Inc, Amicus Therapeutics Inc, Loxo Oncology Inc, Sells Incyte Corp, Aetna Inc, Biogen Inc, Stocks: REGN,LOXO,NVRO,ASMB,DCPH,EVHC,FOLD,RYTM,SCPH,DVA,A, release date:Feb 23, 2018
Feb 23, 2018 - Regeneron, with a productive pipeline and one of the world's largest-selling drugs in Eylea, has been dropping sharply lately.Just this week, major financial media came out with two negative pieces on
Feb 23, 2018 - BioMarin (BMRN) reports wider-than-expected loss in the fourth quarter of 2017 but beat estimates for sales on higher product revenues.
Feb 23, 2018 - Corcept (CORT) reports in-line results for the fourth quarter of 2017 and also announces top-line interim phase II data for its pipeline candidate relacorilant.
Feb 21, 2018 - Entresto will very soon prove to be a blockbuster cardiovascular drug.Cosentyx has the potential to become a blockbuster drug in each of its approved indications.CAR-T therapy, Kymriah, is testimony t
Feb 21, 2018 - Canaccord Genuity issues rating change for REGN
Feb 20, 2018 - The shares of Novavax (NVAX) rose over 8% yesterday.
Feb 20, 2018 - The Zacks Analyst Blog Highlights: Nordisk, TJX, Cigna, Regeneron and ArcelorMittal
Feb 19, 2018 - Regeneron's earnings and revenue projections are strong.The stock price is currently undervalued.The company's extremely strong financial position.Analyst expectations are rising.
Feb 16, 2018 - CELG put out an optimistically-titled press release regarding a mid-stage clinical trial for its newest blockbuster, Otezla.My interpretation of the data is at variance with that of CELG.I see CELG do